微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 58.22% | 4.64% | 2.11% | 56/160 | 22.89% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 57.02% | 14.51% | 6.22% | 63/160 | 33.26% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 53.68% | 17.82% | -4% | 67/160 | 51.37% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 55.92% | 8.32% | 0.5% | 66/160 | 51.37% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 55.64% | 11.79% | 11.74% | 69/160 | 32.75% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 49.79% | -3.25% | 9.29% | 81/160 | 38.61% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 45.56% | -18.14% | -11.74% | 91/160 | 52.91% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 51.62% | 5.07% | 3.73% | 84/160 | 53.57% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 49.77% | 1.38% | -3.29% | 81/160 | 6.69% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 51.46% | 11.53% | -7.53% | 80/160 | 21.79% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 55.66% | 30.1% | 13.28% | 68/160 | 54.47% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 49.13% | 3.98% | 0.08% | 87/160 | 55.07% | 首药控股 | 99.93% | 行业排名> |
| 2021-09-30 | 49.09% | -3.13% | 6.39% | 78/160 | 47.01% | 艾力斯 | 99.41% | 行业排名> |
| 2021-06-30 | 46.14% | -7.69% | 7.86% | 84/160 | 47.45% | 艾力斯 | 98.7% | 行业排名> |
| 2021-03-31 | 42.78% | 2% | -9.46% | 80/160 | 54.21% | 艾力斯 | 99.4% | 行业排名> |
| 2020-12-31 | 47.25% | -7.88% | -6.76% | 87/160 | -143.08% | 首药控股 | 99.94% | 行业排名> |
| 2020-09-30 | 50.68% | 2% | 1.39% | 68/160 | 56.57% | 泽璟制药 | 99.96% | 行业排名> |
| 2020-06-30 | 49.99% | 3.76% | -2.55% | 73/160 | 54.32% | 微芯生物 | 95.14% | 行业排名> |
| 2019-12-31 | 51.3% | 9% | 6.48% | 75/160 | -1204.25% | 多瑞医药 | 95.59% | 行业排名> |
| 2019-06-30 | 48.18% | 2% | 2.38% | 67/160 | 55.36% | 微芯生物 | 95.81% | 行业排名> |
| 2018-12-31 | 47.06% | -3.01% | -3.01% | 78/160 | -205.91% | 微芯生物 | 96.09% | 行业排名> |
| 2017-12-31 | 48.52% | 2% | 2% | 68/160 | 52.58% | 微芯生物 | 96.11% | 行业排名> |